Ausgabe 2/2012
Inhalt (24 Artikel)
Functional analysis and gene expression profile of umbilical cord blood regulatory T cells
Giovanni Fernando Torelli, Roberta Maggio, Nadia Peragine, Sabina Chiaretti, Maria Stefania De Propris, Barbarella Lucarelli, Maria Screnci, Maria Grazia Mascolo, Filippo Milano, Anna Paola Iori, Gabriella Girelli, Anna Guarini, Robin Foà
Anti-leukemic therapies induce cytogenetic changes of human bone marrow-derived mesenchymal stem cells
Su-Peng Yeh, Wen-Jyi Lo, Chiao-Lin Lin, Yu-Min Liao, Chen-Yuan Lin, Li-Yuan Bai, Ji-An Liang, Chang-Fang Chiu
The novel compound OSI-461 induces apoptosis and growth arrest in human acute myeloid leukemia cells
Raminder Singh, Julia Fröbel, Ron-Patrick Cadeddu, Ingmar Bruns, Thomas Schroeder, Daniela Brünnert, Christian Matthias Wilk, Luiz Fernando Zerbini, Rainer Haas, Akos Czibere
Monitoring MRD with flow cytometry: an effective method to predict relapse for ALL patients after allogeneic hematopoietic stem cell transplantation
Xiao-Su Zhao, Yan-Rong Liu, Hong-Hu Zhu, Lan-Ping Xu, Dai-Hong Liu, Kai-Yan Liu, Xiao-Jun Huang
Phenotypic and genetic characterization of adult T-cell acute lymphoblastic leukemia with del(9)(q34);SET-NUP214 rearrangement
Hyojin Chae, Jihyang Lim, Myungshin Kim, Joonhong Park, Yonggoo Kim, Kyungja Han, Seok Lee, Woo Sung Min
Morphology, cytogenetics, and survival in myelodysplasia with del(20q) or ider(20q): a multicenter study
François Mullier, Sylvie Daliphard, Richard Garand, Mélanie Dekeyser, Yvan Cornet, Isabelle Luquet, Pascaline Talmant, Steven Richebourg, Mauricette Jamar, Jean-Michel Dogné, Christian Chatelain, Lucienne Michaux, Bernard Chatelain
Low incidence of long-term respiratory impairment in Hodgkin lymphoma survivors
Irit Avivi, Emilia Hardak, Beatrice Shaham, Mordechai Igla, Jacob M. Rowe, Eldad J Dann
Clinical features and outcomes of Hodgkin’s lymphoma in Korea: Consortium for Improving Survival of Lymphoma (CISL)
Young-Woong Won, Jung Hye Kwon, Soon Il Lee, Sung Yong Oh, Won Seog Kim, Seok Jin Kim, Jong-Ho Won, Kyoung Ha Kim, Seong Kyu Park, Jin Seok Kim, Cheolwon Suh, Dok Hyun Yoon, Joon Seong Park, Min Kyoung Kim, Hawk Kim, Hye Jin Kang, Yeung-Chul Mun, Jae-Yong Kwak, Hyo Jung Kim, Hyeon-Seok Eom
Brain positron emission tomography in splenectomized adults with β-thalassemia intermedia: uncovering yet another covert abnormality
Khaled M. Musallam, Wassim Nasreddine, Ahmad Beydoun, Roula Hourani, Ahmed Hankir, Suzanne Koussa, Mohamad Haidar, Ali T. Taher
Prevalence and progression of monoclonal gammopathy of undetermined significance and light-chain MGUS in Germany
Lewin Eisele, Jan Dürig, Andreas Hüttmann, Ulrich Dührsen, Roland Assert, Beate Bokhof, Raimund Erbel, Klaus Mann, Karl-Heinz Jöckel, Susanne Moebus
Sequential vincristine, adriamycin, dexamethasone (VAD) followed by bortezomib, thalidomide, dexamethasone (VTD) as induction, followed by high-dose therapy with autologous stem cell transplant and consolidation therapy with bortezomib for newly diagnosed multiple myeloma: results of a phase II trial
Hye Jin Kim, Sung-Soo Yoon, Dong Soon Lee, Sang Kyun Sohn, Hyeon Seok Eom, Jung Lim Lee, Joo Seup Chung, Kihyun Kim, Cheolwon Suh, Jong Ho Won, Jin Seok Kim, Joon Seong Park, Hye Jin Kang, Chu Myong Seong, Cheol Soo Kim, Sang Jae Lee, Jae Hoon Lee
Transcriptomic rationale for the synergy observed with dasatinib + bortezomib + dexamethasone in multiple myeloma
Edvan de Queiroz Crusoe, Patricia Maiso, Diego Fernandez-Lazaro, Laura San-Segundo, Mercedes Garayoa, Antonio Garcia-Gomez, Norma C. Gutierrez, Manuel Delgado, Enrique Colado, Jesus Martin-Sanchez, Francis Y. Lee, Enrique M. Ocio
Increased number of B-cells in the red pulp of the spleen in ITP
Bob Olsson, Börje Ridell, Margareta Jernås, Hans Wadenvik
Efficacy of rituximab in immune thrombocytopenic purpura: a retrospective survey
Souleymane Brah, Laurent Chiche, Raphaelle Fanciullino, Charléric Bornet, Julien Mancini, Nicolas Schleinitz, Rodolphe Jean, Gilles Kaplanski, Jean-Robert Harlé, Jean-Marc Durand
Stevens–Johnson/toxic epidermal necrolysis overlap syndrome following lenalidomide treatment for multiple myeloma relapse after allogeneic transplantation
Ralph Wäsch, Thilo Jakob, Kristin Technau, Jürgen Finke, Monika Engelhardt
Parvovirus B19 infection-related acute hepatitis after rituximab-containing regimen for treatment of diffuse large B-cell lymphoma
Shih-Hung Yang, Long-Wei Lin, Yu-Jen Fang, Ann-Lii Cheng, Sung-Hsin Kuo
Immune hemolysis after fludarabine-based reduced intensity conditioning and allogeneic PBSC transplantation for CML with minor ABO incompatibility
Rodolfo Calixto, Fabiana Ostronoff, Mauricio Ostronoff, Alexandre Sucupira, Rodrigo Florêncio, Ana Patricia Souto Maior, Mariana Coutinho Domingues, Visalam Chandrasekaran
Secondary acute myeloid leukaemia after peptide receptor radionuclide therapy
Andrea Piccin, Chiara Maria Grana, Giovanni Negri, Irene Pusceddu, Giovanni Paganelli, Sergio Cortelazzo
Screening for hereditary spherocytosis in routine practice: evaluation of a diagnostic algorithm with focus on non-splenectomised patients
Lies Persijn, Carolien Bonroy, Veerle Mondelaers, Anna Vantilborgh, Jan Philippé, Veronique Stove
Hunter syndrome and new onset idiopathic thrombocytopenic purpura in a young patient
Burak Uz, Haluk Demiroglu, Osman Ilhami Ozcebe
Chronic lymphocytic leukemia developing in a patient with Janus kinase 2 V617F mutation positive myeloproliferative neoplasm
Ahmet Emre Eskazan, Ayse Salihoglu, Reyhan Diz-Kucukkaya, Veysel Sabri Hancer, Teoman Soysal
F-18 Fluorodeoxyglucose non-avid hepatosplenic T cell lymphoma: a diagnostic pitfall
Siu-Lun Ho, Florence Loong, Clarence Lam, Marina-Portia Anthony, Yok-Lam Kwong
Very short-term lenalidomide treatment associated with durable resolution of anemia in a patient with myelodysplastic syndrome with chromosome 5q deletion
Laura Cannella, Roberto Latagliata, Massimo Breccia, Ida Carmosino, Giuseppina Loglisci, Paola Volpicelli, Antonietta Ferretti, Michelina Santopietro, Federico Vozella, Corrado Girmenia, Mariella Cuzzola, Esther Natalie Oliva, Giuliana Alimena